1. Home
  2. FCFS vs ABVX Comparison

FCFS vs ABVX Comparison

Compare FCFS & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FirstCash Holdings Inc.

FCFS

FirstCash Holdings Inc.

HOLD

Current Price

$189.33

Market Cap

8.4B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$122.84

Market Cap

9.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCFS
ABVX
Founded
1988
2013
Country
United States
France
Employees
N/A
67
Industry
Other Specialty Stores
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
9.7B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
FCFS
ABVX
Price
$189.33
$122.84
Analyst Decision
Strong Buy
Buy
Analyst Count
3
13
Target Price
$179.33
$130.85
AVG Volume (30 Days)
242.3K
743.8K
Earning Date
04-23-2026
03-23-2026
Dividend Yield
0.89%
N/A
EPS Growth
29.49
N/A
EPS
7.42
N/A
Revenue
$3,661,043,000.00
N/A
Revenue This Year
$16.17
N/A
Revenue Next Year
N/A
$0.22
P/E Ratio
$25.45
N/A
Revenue Growth
8.04
N/A
52 Week Low
$116.09
$4.77
52 Week High
$199.60
$148.83

Technical Indicators

Market Signals
Indicator
FCFS
ABVX
Relative Strength Index (RSI) 53.68 53.78
Support Level $178.78 $106.37
Resistance Level $199.60 $131.27
Average True Range (ATR) 6.12 5.01
MACD -1.08 1.08
Stochastic Oscillator 42.68 80.07

Price Performance

Historical Comparison
FCFS
ABVX

About FCFS FirstCash Holdings Inc.

FirstCash Holdings Inc is an operator of pawn stores in the U.S., Latin America and the U.K. The company's primary line of business is the operation of retail pawn stores, also known as pawnshops. It also operates a retail POS payment solutions business. Its two business lines are organized into four reportable segments: The U.S. pawn segment consists of pawn operations in some of U.S. states and the District of Columbia; The Latin America pawn segment consists of pawn operations in Mexico, Guatemala, El Salvador and Colombia; The U.K. pawn segment consists of pawn operations in England, Scotland and Wales; and The retail POS payment solutions segment consists of the operations of American First Finance, LLC, which offers products in the U.S.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: